Third-generation human mitochondria-focused cDNA microarray and its bioinformatic tools for analysis of gene expression

BioTechniques

Volumn 42, Issue 3, 2007, Pages 365-375

  Bai, Xueyan ^a   Wu, Jun ^a   Zhang, Qiuyang ^a   Alesci, Salvatore ^b   Manoli, Irini ^b   Blackman, Marc R ^b   Chrousos, George P ^b   Goldstein, Allan L ^a   Rennert, Owen M ^b   Su, Yan A ^a  

^a Ross Hall   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MITOCHONDRIAL DNA;

ARTICLE; BIOLOGY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PROCEDURES; GENETICS; HUMAN; IMAGE PROCESSING; METABOLISM; METHODOLOGY; MITOCHONDRION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TUMOR CELL LINE;

CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DATA INTERPRETATION, STATISTICAL; DNA, COMPLEMENTARY; DNA, MITOCHONDRIAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TECHNIQUES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MITOCHONDRIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34248598086     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/000112388     Document Type: Article

References (44)

1. Scheffler, I.E. 2001. A century of mitochondrial research: achievements and perspectives. Mitochondrion 1:3-31. (Pubitemid 33586018)
2. Margulis, L. 1996. Archaeal-eubacterial mergers in the origin of Eukarya: phylogenetic classification of life. Proc. Natl. Acad. Sci. USA 93:1071-1076.
3. Chinnery, P.F. 2003. Searching for nuclear-mitochondrial genes. Trends Genet. 19:60-62.
4. Zeviani, M., P. Corona, L. Nijtmans, and V. Tiranti. 1999. Nuclear gene defects in mitochondrial disorders. Ital. J. Neurol. Sci. 20:401-408.
5. Leonard, J.V. and A.H. Schapira. 2000. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 355:299-304.
6. Enns, G.M. 2003. The contribution of mitochondria to common disorders. Mol. Genet. Metab. 80:11-26.
7. Boudina, S. and E.D. Abel. 2006. Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology (Bethesda) 21:250-258.
8. Welch, K.M. 1998. Current opinions in headache pathogenesis: introduction and synthesis. Curr. Opin. Neurol. 11:193-197.
9. Wallace, D.C. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39:359-407.
10. Szewczyk, A. and L. Wojtczak. 2002. Mitochondria as a pharmacological target. Pharmacol. Rev. 54:101-127.
11. Dias, N. and C. Bailly. 2005. Drugs targeting mitochondrial functions to control tumor cell growth. Biochem. Pharmacol. 70:1-12.
12. Karunagaran, D., R. Rashmi, and T.R. Kumar. 2005. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr. Cancer Drug Targets 5:117-129.
13. Hu, J., J. Fang, Y. Dong, S.J. Chen, and Z. Chen. 2005. Arsenic in cancer therapy. Anticancer Drugs 16:119-127.
14. Alesci, S., I. Manoli, V.J. Michopoulos, F.M. Brouwers, H. Le, P.W. Gold, M.R. Blackman, O.M. Rennert, et al. 2006. Development of a human mitochondria-focused cDNA microarray (hMitChip) and validation in skeletal muscle cells: implications for pharmaco- and mitogenomics. Pharmacogenomics J. 6:333-342.
15. Manoli, I., H. Le, S. Alesci, K.K. McFann, Y.A. Su, T. Kino, G.P. Chrousos, and M.R. Blackman. 2005. Monoamine oxidase-A is a major target gene for glucocorticoids in human skeletal muscle cells. FASEB J. 19:1359-1361.
16. Trent, J.M., E.J. Stanbridge, H.L. McBride, E.U. Meese, G. Casey, D.E. Araujo, C.M. Witkowski, and R.B. Nagle. 1990. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247:568-571. (Pubitemid 120031340)
17. Su, Y.A., M.E. Ray, T. Lin, N.E. Seidel, D.M. Bodine, P.S. Meltzer, and J.M. Trent. 1996. Reversion of monochromosome-mediated suppression of tumorigenicity in malignant melanoma by retroviral transduction. Cancer Res. 56:3186-3191.
18. Su, Y.A. and J.M. Trent. 2001. Isolation of tumor suppressor genes in melanoma by cDNA microarray. In B.J. Nickoloff (Ed.), Methods in Molecular Medicine. Humana Press, Totowa.
19. Holland, P.M., R.D. Abramson, R. Watson, and D.H. Gelfand. 1991. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA 88:7276-7280.
20. Bolstad, B.M., R.A. Irizarry, M. Astrand, and T.P. Speed. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193.
21. Hartemink, A.J., D.K. Gifford, T.S. Jaakkola, and R.A. Young. 2001. Maximum-likelihood estimation of optimal scaling factors for expression array mormalization, p. 132-140. In Y. Chen, A.N. Dorsel, E.R. Dougherty, and M.L. Bittner (Eds.), Proc. SPIE, Microarrays: Optical Technologies and Informatics. San Jose, CA.
22. Calvo, S., M. Jain, X. Xie, S.A. Sheth, B. Chang, O.A. Goldberger, A. Spinazzola, M. Zeviani, et al. 2006. Systematic identification of human mitochondrial disease genes through integrative genomics. Nat. Genet. 38:576-582.
23. Brandon, M.C., M.T. Lott, K.C. Nguyen, S. Spolim, S.B. Navathe, P. Baldi, and D.C. Wallace. 2005. MITOMAP: a human mitochondrial genome database-2004 update. Nucleic Acids Res. 33:D611-D613. (Pubitemid 40207946)
24. Maitra, A., Y. Cohen, S.E. Gillespie, E. Mambo, N. Fukushima, M.O. Hoque, N. Shah, M. Goggins, et al. 2004. The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res. 14:812-819. (Pubitemid 38660497)
25. van der Westhuizen, F.H., L.P. van den Heuvel, R. Smeets, J.A. Veltman, R. Pfundt, A.G. van Kessel, B.M. Ursing, and J.A. Smeitink. 2003. Human mitochondrial complex I deficiency: investigating transcriptional responses by microarray. Neuropediatrics 34:14-22.
26. Crimi, M., S.F. O'Hearn, D.C. Wallace, and G.P. Comi. 2005. Molecular research technologies in mitochondrial diseases: the microarray approach. IUBMB Life 57:811-818. (Pubitemid 43062402)
27. Alesci, A., Y.A. Su, and G.P. Chrousos. 2004. hMidas and hMitChip: new opportunities in mitochondrial bioinformatics and genomic medicine, p. 329-334. In R.A.S. Long, D.J. Lee, B. Nutter, and M. Zhang (Eds.), Seventeenth IEEE Symposium on Computer-Based Medical Systems. IEEE Computer Society Press. Los Alamitos, CA.
28. Lopez, M.F., B.S. Kristal, E. Chernokalskaya, A. Lazarev, A.I. Shestopalov, A. Bogdanova, and M. Robinson. 2000. High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis 21:3427-3440.
29. Tseng, G.C., M.K. Oh, L. Rohlin, J.C. Liao, and W.H. Wong. 2001. Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects. Nucleic Acids Res. 29:2549-2557.
30. Shippy, R., T.J. Sendera, R. Lockner, C. Palaniappan, T. Kaysser-Kranich, G. Watts, and J. Alsobrook. 2004. Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations. BMC Genomics 5:61. (Pubitemid 39546656)
31. Barash, Y., E. Dehan, M. Krupsky, W. Franklin, M. Geraci, N. Friedman, and N. Kaminski. 2004. Comparative analysis of algorithms for signal quantitation from oligonucleotide microarrays. Bioinformatics 20:839-846. (Pubitemid 38559723)
32. Wu, W., N. Dave, G.C. Tseng, T. Richards, E.P. Xing, and N. Kaminski. 2005. Comparison of normalization methods for CodeLink Bioarray data. BMC Bioinformatics 6:309. (Pubitemid 43064703)
33. Park, T., S.G. Yi, S.H. Kang, S. Lee, Y.S. Lee, and R. Simon. 2003. Evaluation of normalization methods for microarray data. BMC Bioinformatics 4:33. (Pubitemid 38751237)
34. Wu, W., E.P. Xing, C. Myers, I.S. Mian, and M.J. Bissell. 2005. Evaluation of normalization methods for cDNA microarray data by k-NN classification. BMC Bioinformatics 6:191. (Pubitemid 41372475)
35. Churchill, G.A. 2002. Fundamentals of experimental design for cDNA microarrays. Nat. Genet. 32(Suppl):490-495.
36. Novoradovskaya, N., M.L. Whitfield, L.S. Basehore, A. Novoradovsky, R. Pesich, J. Usary, M. Karaca, W.K. Wong, et al. 2004. Universal Reference RNA as a standard for microarray experiments. BMC Genomics 5:20.
37. Attoor, S., E.R. Dougherty, Y. Chen, M.L. Bittner, and J.M. Trent. 2004. Which is better for cDNA-microarray-based classification: ratios or direct intensities. Bioinformatics 20:2513-2520.
38. Peixoto, B.R., R.Z. Vencio, C.M. Egidio, L. Mota-Vieira, S. Verjovski-Almeida, and E.M. Reis. 2006. Evaluation of referencebased two-color methods for measurement of gene expression ratios using spotted cDNA microarrays. BMC Genomics 7:35.
39. Huang, W., D. Tan, X. Wang, S. Han, J. Tan, Y. Zhao, J. Lu, and B. Huang. 2006. Histone deacetylase 3 represses p15(INK4b) and p21(WAF1/cip1) transcription by interacting with Sp1. Biochem. Biophys. Res. Commun. 339:165-171.
40. Robertson, K.D., S. Ait-Si-Ali, T. Yokochi, P.A. Wade, P.L. Jones, and A.P. Wolffe. 2000. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 25:338-342.
41. Won, K.A., R.J. Schumacher, G.W. Farr, A.L. Horwich, and S.I. Reed. 1998. Maturation of human cyclin E requires the function of eukaryotic chaperonin CCT. Mol. Cell. Biol. 18:7584-7589.
42. Lacombe, M.L., L. Milon, A. Munier, J.G. Mehus, and D.O. Lambeth. 2000. The human Nm23/nucleoside diphosphate kinases. J. Bioenerg. Biomembr. 32:247-258.
43. Rosmarin, A.G., K.K. Resendes, Z. Yang, J.N. McMillan, and S.L. Fleming. 2004. GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions. Blood Cells Mol. Dis. 32:143-154.
44. Rosen, E.D., P. Sarraf, A.E. Troy, G. Bradwin, K. Moore, D.S. Milstone, B.M. Spiegelman, and R.M. Mortensen. 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4:611-617.